Form D — Octave Bioscience Inc
0001702278-25-000002 · filed 2025-03-24
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Total offering
- $53,674,121
- Total sold
- $31,840,355
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Octave Bioscience Inc
- CIK
- 1702278
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1440 O'BRIEN DRIVE
MENLO PARK, CA 94025 - Phone
- 917-838-2865
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
William Hagstrom · DirectorMENLO PARK, CA Find on LinkedIn ↗
-
Doug Biehn · Executive OfficerMENLO PARK, CA Find on LinkedIn ↗
-
Brook Byers · DirectorMENLO PARK, CA Find on LinkedIn ↗
-
Thomas Hawes · DirectorMENLO PARK, CA Find on LinkedIn ↗
-
A. Grant Heidrich III · DirectorMENLO PARK, CA Find on LinkedIn ↗
-
Lucy Coassin · DirectorMENLO PARK, CA Find on LinkedIn ↗
-
Michael Pellini · DirectorMENLO PARK, CA Find on LinkedIn ↗
-
George Scangos · DirectorMENLO PARK, CA Find on LinkedIn ↗
-
Marcel Konrad · Executive OfficerMENLO PARK, CA Find on LinkedIn ↗
View original on SEC EDGAR.